相关实验视频

Updated: Jun 16, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

通过虚拟查和分子动力学方法从ConMedNP图书馆中识别潜在的二二酶IV抑制剂

Hans Merlin Tsahnang Fofack^1,2, Maraf Mbah Bake^3,4, Simon Petry⁵

¹Laboratoire Optique et Applications, Centre de Physique Atomique Moleculaire et Optique Quantique, Faculte des Sciences, Université de Douala, B.P. 8580, Douala, Cameroon.

|August 21, 2024

概括

研究人员确定了三种新型的二二酶IV (DPP4) 抑制剂,它们对治疗2型糖尿病具有高结合亲和力. 分子模拟证实了DPP4活性部位内的稳定结合和相互作用.

科学领域:

药用化学医学化学
计算机化药物发现技术
药理学药理学是指药理学的学科.

背景情况:

双基酸酶IV (DPP4) 是2型糖尿病治疗的关键标.
需要新的抑制剂来提高治疗疗效和减少副作用.
康美德NP图书馆提供了一系列用于药物查的多样化分子.

研究的目的:

选ConMedNP图书馆的新型二二酶IV (DPP4) 抑制剂.
使用计算方法评估潜在的DPP4抑制剂的结合亲和力和稳定性.
确定治疗2型糖尿病的有前途的候选药物.

主要方法:

来自ConMedNP图书馆的3507个分子的选.
分子对接和ADMET预测,以评估结合亲和和药物相似性.
分子动力学 (MD) 模拟 (200 ns) 来分析结合稳定性和相互作用.

主要成果:

三种化合物 (OTH_UD_XX06_1,GB19,BMC_000104) 对DPP4.4具有很高的结合亲和力.
MD模拟证实了稳定的结合姿势和DPP4活性部位的持续占用.
在抑制剂和DPP4之间观察到一致的分子间结和疏水相互作用.

结论:

已识别的化合物是强大的DPP4抑制剂,有可能用于2型糖尿病治疗.
计算方法成功预测了DPP4活性部位的稳定结合和关键相互作用.
这些发现为进一步开发新型抗糖尿病药物提供了坚实的基础.

关键词:

在ConMedNP图书馆.双基酸酶IV (DPP4) 是一种双基酸酶.抑制剂是一种抑制剂.分子动力学分子动力学虚拟选是一个虚拟的选.

更多相关视频

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

相关概念视频

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...